Synthesis, molecular docking, and in silico ADME/Tox profiling studies of new 1-aryl-5-(3-azidopropyl)indol-4-ones: Potential inhibitors of SARS CoV-2 main protease
Francisco Xavier Domínguez-Villa, Noemi Angeles Durán-Iturbide, José Gustavo Ávila‐Zárraga
Topics & Concepts
ADMEIn silicoChemistryPharmacologyDocking (animal)Lipinski's rule of fivePharmacokineticsBioavailabilityProteaseSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Computational biologyDrugCoronavirus disease 2019 (COVID-19)BiochemistryEnzymeBiologyVeterinary medicineGeneMedicineDiseaseInfectious disease (medical specialty)PathologyComputational Drug Discovery MethodsSynthesis and biological activityClick Chemistry and Applications